pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-635 |
Genomic Coordinates | chr17: 68424451 - 68424548 |
Synonyms | MIRN635, hsa-mir-635, MIR635 |
Description | Homo sapiens miR-635 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-635 | |||||||||||||||||||||||||||
Sequence | 16| ACUUGGGCACUGAAACAAUGUCC |38 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | SAGE | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | POF1B | ||||||||||||||||||||
Synonyms | POF, POF2B | ||||||||||||||||||||
Description | premature ovarian failure, 1B | ||||||||||||||||||||
Transcript | NM_024921 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on POF1B | |||||||||||||||||||||
3'UTR of POF1B (miRNA target sites are highlighted) |
>POF1B|NM_024921|3'UTR 1 ATGGATCCACTTTAAAGTATTACAACTCAAAGCCGTTTTTTTTTTGTGTGTGTGTCTCTGCATTAGTACTTTGTTATTTT 81 TCCATCACTAAAGGCCAATCAGAATTTGGAACCATGCTGCTACCCAAGAAATCTAATGGAATGAATTAGTTCTGTAGATG 161 ACAATTTCTTCACCCATTTATGAGACCTAAATCTTTTCCATAACACTCATGTATTCAGTATAACAACATACTAACTGAAA 241 GAGGGACCTGATTGTTTAAAGTTTGATTGCAGACACTGTAGAACATAACTCATTATGTTTCAGATAAGGTAACTCCTAGA 321 TATCAAACTAATTTGTTGGGGTAGAGATTTTACAAGTCATGCCATTAGAAGATTTTCTCTGATATTATATGTGCAGTTCA 401 GTTACAAGATGAAATCATGTTTTTTTAACAAAAGAGATAAAATACAATTGAAGCAAAAAATAACAGCTAGTATATAATAT 481 ATACAGTCTGTATTTGCTTTTCACAGTAGGCCTGATGACTAAAAGATATGCTTTATTACACGCTATTTTCACCTCTTGAA 561 AGTCAAAGGTGATGATTAATTTCATTTAGCAGGGAAGTGGAATAATATCTTTTGAAATAACTAAGTCCACTAAATTATAC 641 AGTATGCTATTCTGGTTCTAAGTACATATTAGTCCCTTGGCAAATCTGTTCTTTCAAAGCATACCTTCCCCAAATGAGCC 721 TACCTACTTCTTAAAAAACATATAACACAATGTGGTAGTAGTAGGTGTAAGGAAGGTAAGTTTTTTCATAGTGGTATGCA 801 AACATATCATTGAAATATTACATAGATATAAAGACTTAGGGAATAAAAATAGCAGCAACAAATACTTGATAGATTTATCC 881 TACTTGGGAGAAATATTTTGTAGCAGAGTATTTAGTATACTTAGAAGTTGATTTAGCAATTAGGCTTTAATGACCTTACA 961 AAGTGAACATAACTGAACACAAGTATTTTTTCAATGCAAGATGAGGATGAAAATTTTACATTTCAACCCATCTGGCTAAA 1041 GTTAAGACTTAGCAAAAATTAAAATGTTGCCTTTGTCCAAGTATAGATTAAGGCAACAAACATATTTGGGTGTGTAATTT 1121 GAAGTTTTGGACTGAAATATCTTTGCAAGTATCCACATAAAATTCTGTAATGCCTTATAATTATATTCTAATAATTATGC 1201 ATTATACTAAGACACCATTAAGAACAGTTGAGGCACTACACTAAATCAAACCATAAATGAGGAAAAAACTTTTAATGTTC 1281 TTTTCTAGAAGTGTTCAAATAGGTCTTGATATGAAGCTAAAAGCCTTATTTATATTATCTTAATATTTCGGCTAAAATGT 1361 TAAGCTCCATAACATGAATTGATACAATTCCAATTTTATCAATATTTTGTGATAGAAAAATGTTAATATTATTCATGAGC 1441 TATACAGTCCTTACATTTTTTCCCTTGGTGTAGGAACAACGGAGGAGTTTCTCCTCTGCTAACTATTCATATATGTAACT 1521 GTAACAAAAGTGTACTATGTTATGCACACATTACAAATAATATAAGGGGAAGTTTTATTAGCTTAGTAGGAAATTGTTAT 1601 TATTAAGGTTTAAAAATGAGAACAGGTGTGAGTTTTCCAAAATACTTAAAAATAATAGTGTCAAAAATTCAGGGGCAGTT 1681 AAGGAGTCATGGATGGAACTAGAGGTCACTATATTAAGTGACATAAGCCAGAAACAGACAAACATTGCATGTTCTCAATT 1761 ATTTGCGGGATCTAAAAGTCAAAACAATTGAACTCATGGATATAGAGAGTAGAAGGATGGTTACTAGTGGCTGGGAAAAG 1841 GGGTGTGCGAGGGGAACTGGGGATGCTTAATGTGTACAAAAACTATGTAGTTAGAAAGTATAAATAAGACCTAGTATTTG 1921 ATAGCACAACCGGGTGAGTATAGTCAATAATAGCTTAATTGTACAAATAACTAAGAGTATAATTGGATTGTTTGTAACAC 2001 AAATAAATACTTGAGTGGATGGATACCCAATTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 79983.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000262753.4 | 3UTR | GAAAUCUAAUGGAAUGAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
48 hsa-miR-635 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT055249 | CNNM2 | cyclin and CBS domain divalent metal cation transport mediator 2 | 2 | 2 | ||||||||
MIRT150167 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT198486 | USP14 | ubiquitin specific peptidase 14 | 2 | 6 | ||||||||
MIRT446204 | GTPBP4 | GTP binding protein 4 | 2 | 2 | ||||||||
MIRT453083 | SUMF2 | sulfatase modifying factor 2 | 2 | 6 | ||||||||
MIRT462505 | MTFMT | mitochondrial methionyl-tRNA formyltransferase | 2 | 8 | ||||||||
MIRT474413 | KLHL28 | kelch like family member 28 | 2 | 8 | ||||||||
MIRT479376 | CELF1 | CUGBP Elav-like family member 1 | 2 | 4 | ||||||||
MIRT498090 | SEMA7A | semaphorin 7A (John Milton Hagen blood group) | 2 | 2 | ||||||||
MIRT525565 | MTRNR2L7 | MT-RNR2-like 7 | 2 | 6 | ||||||||
MIRT525613 | MTRNR2L3 | MT-RNR2-like 3 | 2 | 4 | ||||||||
MIRT531868 | POF1B | premature ovarian failure, 1B | 2 | 2 | ||||||||
MIRT535789 | MTRNR2L11 | MT-RNR2-like 11 | 2 | 6 | ||||||||
MIRT535807 | MTRNR2L10 | MT-RNR2-like 10 | 2 | 4 | ||||||||
MIRT539940 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT563194 | C15orf38-AP3S2 | C15orf38-AP3S2 readthrough | 2 | 2 | ||||||||
MIRT563803 | AP3S2 | adaptor related protein complex 3 sigma 2 subunit | 2 | 2 | ||||||||
MIRT576360 | Pxdn | peroxidasin | 2 | 2 | ||||||||
MIRT615575 | NCS1 | neuronal calcium sensor 1 | 2 | 2 | ||||||||
MIRT620858 | SERPING1 | serpin family G member 1 | 2 | 2 | ||||||||
MIRT623189 | NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit | 2 | 2 | ||||||||
MIRT625116 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT625128 | NUP93 | nucleoporin 93 | 2 | 2 | ||||||||
MIRT625904 | LINC00632 | long intergenic non-protein coding RNA 632 | 2 | 2 | ||||||||
MIRT626820 | PRR11 | proline rich 11 | 2 | 2 | ||||||||
MIRT628142 | HM13 | histocompatibility minor 13 | 2 | 2 | ||||||||
MIRT633789 | ZNF490 | zinc finger protein 490 | 2 | 2 | ||||||||
MIRT634385 | RAP2B | RAP2B, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT636563 | EPB41 | erythrocyte membrane protein band 4.1 | 2 | 2 | ||||||||
MIRT643446 | LAX1 | lymphocyte transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT646006 | HTRA1 | HtrA serine peptidase 1 | 2 | 2 | ||||||||
MIRT652141 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT652672 | TIMELESS | timeless circadian clock | 2 | 2 | ||||||||
MIRT658341 | FAM83D | family with sequence similarity 83 member D | 2 | 2 | ||||||||
MIRT658890 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT659518 | CHST3 | carbohydrate sulfotransferase 3 | 2 | 2 | ||||||||
MIRT668590 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT670258 | ZKSCAN3 | zinc finger with KRAB and SCAN domains 3 | 2 | 2 | ||||||||
MIRT686721 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT701899 | MNT | MAX network transcriptional repressor | 2 | 2 | ||||||||
MIRT702764 | IGF1R | insulin like growth factor 1 receptor | 2 | 2 | ||||||||
MIRT705290 | B4GALT1 | beta-1,4-galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT710836 | BASP1 | brain abundant membrane attached signal protein 1 | 2 | 2 | ||||||||
MIRT711732 | NUPL2 | nucleoporin like 2 | 2 | 2 | ||||||||
MIRT717619 | SLC30A10 | solute carrier family 30 member 10 | 2 | 2 | ||||||||
MIRT719453 | APBA1 | amyloid beta precursor protein binding family A member 1 | 2 | 2 | ||||||||
MIRT720819 | CIAO1 | cytosolic iron-sulfur assembly component 1 | 2 | 2 | ||||||||
MIRT723454 | CUL4A | cullin 4A | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|